US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

296.31

+0.55000.19%

Post-market: 297.220.9100+0.31%17:16 EDT

Volume:259.64K

Turnover:74.85M

Market Cap:570.24M

PE:- -

High:300.34

Open:290.97

Low:281.50

Close:295.76

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.68

T/O Rate:13.49%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

ISEC Healthcare Forms Joint Venture for New Ophthalmology Centre in Johor

Modern Healthcare Technology Flags Lease Deals After Disclosure Oversight

Labcorp to Present at Morgan Stanley Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Kazia Therapeutics (KZIA) and Cerus (CERS)

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live

Community Healthcare (CHCT) Receives a Buy from Truist Financial

Centene (CNC) Receives a Buy from Bernstein

US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech

Yestar Healthcare Swings to Small Interim Loss Despite Higher Gross Profit

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

Ord Minnett Remains a Buy on Sigma Healthcare Ltd (S5YA)

IHH Healthcare Outlook Likely to be Supported by Resilient Patient Demand

AMN Healthcare Services (AMN) After AONL Move Looks Fully Valued Near $35

Simply Wall St.

Sigma Healthcare Ltd (S5YA) Receives a Buy from Morgan Stanley

Ramsay Health Care (RMSYF) Gets a Sell from Morgan Stanley

Memphasys Accelerates Felix Launch After Early Thai FDA Approval

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

Health Care Down on Rotation to Tech

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

Roivant Sciences Gets FDA Approval for LISRAYA in Dermatomyositis; Shares Rise

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/LABU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":296.31,"timestamp":1788206400000,"preClose":295.76,"halted":0,"volume":259643,"hourTrading":{"tag":"盘后","latestPrice":297.22,"preClose":296.31,"latestTime":"17:16 EDT","volume":791,"amount":234445.6765,"timestamp":1788210982318,"change":0.91,"changeRate":0.003071,"amplitude":0.011137},"delay":0,"changeRate":0.0018596159047877042,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Post-Mkt","change":0.55,"latestTime":"08-31 17:38:31 EDT","open":290.97,"high":300.34,"low":281.5,"amount":74846833.23475,"amplitude":0.0637,"askPrice":297.44,"askSize":3,"bidPrice":279.9,"bidSize":3,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":295.76,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.003394,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":288.18,"preClose":295.76,"latestTime":"09:29 EDT","volume":1523,"amount":449603.04808999994,"timestamp":1788182999999,"change":-7.58,"changeRate":-0.025629,"amplitude":0.050003},"postHourTrading":{"tag":"盘后","latestPrice":297.22,"preClose":296.31,"latestTime":"17:16 EDT","volume":791,"amount":234445.6765,"timestamp":1788210982318,"change":0.91,"changeRate":0.003071,"amplitude":0.011137},"volumeRatio":0.684409,"impliedVol":0.9253,"impliedVolPercentile":0.5737},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.684409,"shares":1924486,"dividePrice":1.0056,"high":300.34,"amplitude":0.0637,"preClose":295.76,"low":281.5,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":296.31,"eps":0,"divideRate":0.003394,"volume":259643,"delay":0,"ttmEps":0,"open":290.97,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":308.33,"twentyDayClose":228.04,"sixtyDayClose":179.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662109234","title":"ISEC Healthcare Forms Joint Venture for New Ophthalmology Centre in Johor","url":"https://stock-news.laohu8.com/highlight/detail?id=2662109234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662109234?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:38","pubTimestamp":1787931493,"startTime":"0","endTime":"0","summary":"ISEC Healthcare Ltd ( ($SG:40T) ) has issued an announcement. ISEC Healthcare is deepening its Malaysian footprint with a new joint venture to esta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/isec-healthcare-forms-joint-venture-for-new-ophthalmology-centre-in-johor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/isec-healthcare-forms-joint-venture-for-new-ophthalmology-centre-in-johor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JYNT","BK4581","BK4185","BK4137","BK4588","SG","XBI","LU0029874061.USD","HCSG","BK4585","BK4209","LABU","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662944020","title":"Modern Healthcare Technology Flags Lease Deals After Disclosure Oversight","url":"https://stock-news.laohu8.com/highlight/detail?id=2662944020","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662944020?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:16","pubTimestamp":1787930182,"startTime":"0","endTime":"0","summary":"The latest update is out from Modern Healthcare Technology Holdings Limited ( ($HK:0919) ). Modern Healthcare Technology Technology Holdings Limite...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/modern-healthcare-technology-flags-lease-deals-after-disclosure-oversight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/modern-healthcare-technology-flags-lease-deals-after-disclosure-oversight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4585","HCSG","LU0029874061.USD","XBI","LU0128526141.USD","BK4588","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662009682","title":"Labcorp to Present at Morgan Stanley Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662009682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662009682?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:36","pubTimestamp":1787924191,"startTime":"0","endTime":"0","summary":"Labcorp Holdings ( ($LH) ) has issued an announcement. Labcorp Holdings Inc., a global leader in diagnostics and drug development laboratory servic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","BK4585","BK4137","LU0128526141.USD","LU0029874061.USD","BMED","LFSC","XLV","XBI","BK4588","LABU","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662109639","title":"Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Kazia Therapeutics (KZIA) and Cerus (CERS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662109639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662109639?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:30","pubTimestamp":1787923834,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Healthequity (HQY), Kazia Therapeutics (KZIA) and Ce...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-healthequity-hqy-kazia-therapeutics-kzia-and-cerus-cers-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-healthequity-hqy-kazia-therapeutics-kzia-and-cerus-cers-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1169589451.USD","XBI","LU2210149790.SGD","BK4154","BK4139","XLV","LU2095319765.USD","CERS","BK4137","LABU","LU1169590202.USD","LU2210150020.SGD","LU0128526141.USD","KZIA","LU0029874061.USD","BK4585","BK4588","BK4198","HQY","LU2065731478.USD","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662966095","title":"Sector Update: Health Care Stocks Mixed Pre-Bell Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662966095","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662966095?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:17","pubTimestamp":1787923054,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF  gaining by 0.1% and the iShares Biotechnology ETF  down 0.6%.Cytokinetics  shares were down 4%, extending the 1.6% loss in the previous session. The company said Friday that its phase 3 clinical trial of aficamten in symptomatic non-obstructive hypertrophic cardiomyopathy met both primary endpoints.Hutchmed's  stock was up 1% after the company said a new drug application for fanregratinib to treat liver cancer has been granted conditional approval by China's National Medical Products Administration.Eli Lilly  stock was up 0.5% after the company said the US Food and Drug Administration approved Mounjaro to lower the risk of major adverse cardiovascular events in adults with type 2 diabetes who are at high risk for those events.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1069344957.HKD","LU1145028129.USD","LU0133085943.USD","LU1127390331.HKD","LU0061475181.USD","BK4533","GB00BDT5M118.USD","LU2461242641.AUD","PPH","LU1093756325.SGD","IXJ","BK4516","LU2361044865.SGD","LU2552382132.HKD","LU0203202063.USD","LU2168564065.EUR","LU0820561818.USD","LU1974910355.USD","LU2471134952.CNY","LU2750360641.GBP","IE00B1BXHZ80.USD","LU0238689110.USD","LU1720051108.HKD","MEDI","IBB","LU2746668974.SGD","LU2417539215.USD","IE00BFSS7M15.SGD","LU1988902786.USD","IE0005OL40V9.USD","IE00BKPKM429.USD","LU2106854487.HKD","LU1804176565.USD","LU2552382058.USD","RXL","BK4585","LLYX","IE00B775H168.HKD","IE00B4JS1V06.HKD","SG9999014880.SGD","LU0640476718.USD","LU2471134879.HKD","SG9999015986.USD","IE00BJJMRX11.SGD","LU2471134523.USD","LU2168564149.EUR","LU2237443382.USD","LU2896262040.SGD","LU1917777945.USD","LABU","LU2750360997.AUD","LU0097036916.USD","IHE","LU2491050071.SGD","LU2324357040.USD","SG9999001176.USD","SG9999013999.USD","SGXZ51526630.SGD","LU0432979614.USD","LU0158827781.USD","LU0353189680.USD","THNR","LU2471134796.USD","LU1023059063.AUD","LU1551013342.USD","LU0672654240.SGD","LU1712237335.SGD","SGXZ99366536.SGD","SG9999014906.USD","SG9999018865.SGD","LU0354030511.USD","WDNA","IYH","TRUH","LU0823434583.USD","LU1548497426.USD","SG9999014914.USD","LU0198837287.USD","LU2462157665.USD","LU0006306889.USD","LU1061106388.HKD","LU0882574139.USD","BK4588","IE00BWXC8680.SGD","LU0943347566.SGD","LU0820562030.AUD","LU2237443978.SGD","LLYZ","LU2462591350.SGD","PJP","LU0225283273.USD","LU1720051017.SGD","LU2237443895.HKD","LU0234572021.USD","IE0009355771.USD","LU0466842654.USD","LU1989771016.USD","LU0174119429.USD","LU0882574055.USD","LLII","LU0786609619.USD","SGXZ57979304.SGD","VHT","LU0689472784.USD","LU0708995401.HKD","LU0256863811.USD","LU1035775433.USD","SG9999018857.SGD","LU0456855351.SGD","LU2089283258.USD","GDOC","LU2491050154.USD","LU0109391861.USD","LU2237443622.USD","LU0889565916.HKD","LU2361044949.HKD","LU0096364046.USD","BK4531","00013","XLV","SGXZ31699556.SGD","LU1291159041.SGD","LU0787776722.HKD","LU2357305700.SGD","LU1280957306.USD","ELIS","LU2236285917.USD","LU1267930730.SGD","LU1551013425.SGD","LU0320765992.SGD","LU0203201768.USD","LU2087625088.SGD","LU2237443465.HKD","IE00BJLML261.HKD","LU0345770308.USD","BK4007","LU2271345857.HKD","LU0823416689.USD","LU2361045086.USD","IE00BJJMRY28.SGD","LU1057294990.SGD","LU0210536198.USD","LU2237443549.SGD","IE0004445015.USD","SG9999017495.SGD","BK4505","IE00BJJMRZ35.SGD","LU2602419157.SGD","AGNG","CANC","LU1868836591.USD","LU2168564222.USD","LU2213496289.HKD","IE00BKDWB100.SGD","IE00BN29S564.USD","LU0471298777.SGD","LU2264538146.SGD","LU2756315664.SGD","LU0820561909.HKD","LU0417517546.SGD","LU2063271972.USD","LU2111349929.HKD","OZEM","LU1366192091.USD","CYTK","ILDR","LU2456880835.USD","IE00B7KXQ091.USD","IE00BK4W5L77.USD","LU1623119135.USD","SG9999001176.SGD","LU2211815571.USD","FTXH","LU2360106947.USD","IE00BK4W5M84.HKD","BK4139","SG9999015945.SGD","LU1814569148.SGD","LU2237438978.USD","IE0002141913.USD","LU0094547139.USD","LU0320765059.SGD","LU0106261372.USD","LU0122379950.USD","LU0266013472.USD","LU0471298694.HKD","LU2168564495.EUR","LU1868836914.USD","BK4599","IE0001KFT4U8.USD","LU0114720955.EUR","LU1064131342.USD","MEDX","LU0256863902.USD","LU2552382215.SGD","IE00BJT1NW94.SGD","SG9999015952.SGD","LU0353189763.USD","LU1983299246.USD","LU2089984988.USD","BK4534","LU2112291526.USD","LU0058720904.USD","SG9999014898.SGD","LU2265009873.SGD","XBI","BK4581","MHIP","IE00B2B36J28.USD","ELIL","LU1232071149.USD","LU0354030438.USD","IE00BFSS8Q28.SGD","LU2491049909.HKD","LU0109394709.USD","LU1868837300.USD","SGXZ81514606.USD","LU2108987350.USD","CURE","LU1093756168.USD","LU2023250330.USD","HRTS","LU2089284900.SGD","LU0345770993.USD","IE00B1XK9C88.USD","LLY","LU0158827948.USD","LU2756315318.SGD","LU2023251221.USD","LU0823434740.USD","LU2028103732.USD","LU2468319806.SGD","LU0316494557.USD","LU0289739699.SGD","LU0079474960.USD","LU0323591593.USD","LU1629891620.HKD","LU1868836757.USD","LU2023250504.SGD","LU2746668461.USD","TMED","IE0004445239.USD","LU0385154629.USD","LU2168563687.JPY","LU1323610961.USD","SG9999015978.USD","FHLC","LU1868837136.USD","HCM","LU0683600562.USD","LU1979441026.SGD","IE00BFTCPJ56.SGD","LU0964807845.USD","IE00B4R5TH58.HKD","JDOC","LU1691799644.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060937","title":"Community Healthcare (CHCT) Receives a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060937","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060937?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:55","pubTimestamp":1787918140,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on Community Healthcare, with a price target of $18.00. Lew...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/community-healthcare-chct-receives-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/community-healthcare-chct-receives-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","KBWY","XLV","LABU","BK4581","BK4203","CHCT","XBI","BK4585","BK4225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662106254","title":"Centene (CNC) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2662106254","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662106254?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:56","pubTimestamp":1787914567,"startTime":"0","endTime":"0","summary":"Bernstein analyst Lance Wilkes assigned a Buy rating to Centene today and set a price target of $79.00. Wilkes covers the Healthcare sector, focusi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/centene-cnc-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/centene-cnc-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCG","LU0130103400.USD","LU1201861249.SGD","LU1699723380.USD","LU0130102774.USD","LU0477156797.USD","BK4581","LU0859254822.USD","LU2065171311.SGD","LU2362541513.USD","XLV","LU0130518102.USD","LU1989771016.USD","LU2362540622.SGD","LU0648001328.SGD","LU2065169927.USD","LU0477156953.USD","XBI","LU1201861165.SGD","LU2362541273.HKD","LU2065171402.SGD","LU2065170008.USD","IE0034235188.USD","LU0648000940.SGD","CNC","LU0130517989.USD","LU2357627491.SGD","BK4588","LU1291159041.SGD","BK4585","LU0980610538.SGD","LABU","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145744656","title":"US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=1145744656","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145744656?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:24","pubTimestamp":1787912643,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has officially approved Revolution Medicines' self-developed pancreatic cancer treatment, Rasonque, this week. This approval represents a significant triumph for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","IE00B2B36J28.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LABU","IE0009354923.USD","IE0009355771.USD","LU0109394709.USD","PTH","IE00BJT1NW94.SGD","RVMD","LU0889565916.HKD","LU0320765992.SGD","CANC","BK4585","IDNA","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061335","title":"Yestar Healthcare Swings to Small Interim Loss Despite Higher Gross Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061335","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061335?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:18","pubTimestamp":1787912288,"startTime":"0","endTime":"0","summary":"Yestar Healthcare Holdings Co Ltd ( ($HK:2393) ) just unveiled an update. Yestar Healthcare reported unaudited interim revenue of RMB661.6 million ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yestar-healthcare-swings-to-small-interim-loss-despite-higher-gross-profit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yestar-healthcare-swings-to-small-interim-loss-despite-higher-gross-profit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","BK4588","BK4581","XBI","BK4585","LU0029874061.USD","BK4137","HCSG","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662619610","title":"Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662619610","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662619610?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:17","pubTimestamp":1787912220,"startTime":"0","endTime":"0","summary":"Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/28/3352601/0/en/teva-announces-proposed-acquisition-of-a-novel-neuroscience-product-reinforcing-disciplined-business-development-approach-under-pivot-to-growth-strategy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","BK4588","LABU","BK4550","VHT","NOBL","TCAF","BK4585","CGCV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662056228","title":"Ord Minnett Remains a Buy on Sigma Healthcare Ltd (S5YA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662056228","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662056228?lang=en_us&edition=fundamental","pubTime":"2026-08-28 13:17","pubTimestamp":1787894279,"startTime":"0","endTime":"0","summary":"In a report released today, Tom Godfrey from Ord Minnett maintained a Buy rating on Sigma Healthcare Ltd, with a price target of A$3.40. According ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ord-minnett-remains-a-buy-on-sigma-healthcare-ltd-s5ya-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ord-minnett-remains-a-buy-on-sigma-healthcare-ltd-s5ya-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4137","LU0029874061.USD","BK4581","LABU","LU0128526141.USD","BK4585","HCSG","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662535520","title":"IHH Healthcare Outlook Likely to be Supported by Resilient Patient Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662535520","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662535520?lang=en_us&edition=fundamental","pubTime":"2026-08-28 11:27","pubTimestamp":1787887620,"startTime":"0","endTime":"0","summary":"0327 GMT - IHH Healthcare's near-term growth prospects are supported by resilient demand for quality healthcare, improving patient numbers and ongoing capacity expansion, Public Investment Bank says in a note. Growth in its Malaysia business should remain supported by medical tourism and same-day medical procedures, it says. Its Singapore business is expected to recover in 2H as hospital occupancy and margins improve, it adds. Public Investment Bank maintains its rating on IHH at outperform and its target price at 11.43 ringgit. Shares are 1.0% higher at 8.23 ringgit.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0029874061.USD","HCSG","XBI","BK4137","BK4581","XLV","LABU","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662605557","title":"AMN Healthcare Services (AMN) After AONL Move Looks Fully Valued Near $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2662605557","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662605557?lang=en_us&edition=fundamental","pubTime":"2026-08-28 11:25","pubTimestamp":1787887548,"startTime":"0","endTime":"0","summary":"AMN Healthcare Services (AMN) recently joined the AONL Foundation Corporate Advisory Council, aligning its nursing leadership efforts with the company’s expansion into technology enabled workforce platforms and automation, which are influencing investor attention.\nOver the past year, AMN Healthcare Services has seen a sharp shift in sentiment, with the share price climbing strongly, including a 21.09% 90 day share price return and 132.01% year to date share price return. The 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/amn-healthcare-services-amn-after-aonl-move-looks-fully-valu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/amn-healthcare-services-amn-after-aonl-move-looks-fully-valu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","BK7095","XLV","AMN","XBI","AMN.AU","BK4581","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662037042","title":"Sigma Healthcare Ltd (S5YA) Receives a Buy from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037042","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037042?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:35","pubTimestamp":1787880935,"startTime":"0","endTime":"0","summary":"In a report released today, Melinda Baxter from Morgan Stanley maintained a Buy rating on Sigma Healthcare Ltd, with a price target of A$3.30. Acco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sigma-healthcare-ltd-s5ya-receives-a-buy-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sigma-healthcare-ltd-s5ya-receives-a-buy-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XLV","BK4581","LU0128526141.USD","BK4585","LABU","HCSG","BK4588","BK4137","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662020037","title":"Ramsay Health Care (RMSYF) Gets a Sell from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662020037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662020037?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:35","pubTimestamp":1787880929,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst David Bailey maintained a Sell rating on Ramsay Health Care today and set a price target of A$40.90. According to TipRanks, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-sell-from-morgan-stanley-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-sell-from-morgan-stanley-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4588","BK4185","RMSYF","BK4585","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031640","title":"Memphasys Accelerates Felix Launch After Early Thai FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031640","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031640?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:18","pubTimestamp":1787872720,"startTime":"0","endTime":"0","summary":"Memphasys Ltd ( ($AU:MEM) ) has provided an update. Memphasys Limited has secured early approval from the Thai Food and Drug Administration for its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/memphasys-accelerates-felix-launch-after-early-thai-fda-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/memphasys-accelerates-felix-launch-after-early-thai-fda-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEM","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036059","title":"Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036059","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036059?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:55","pubTimestamp":1787867719,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced that the FDA approved Bixlenvo – bictegravir 75 mg/lenacapavir 50 mg -, the smallest once-daily single tablet regi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","LABU","LU0965509101.SGD","LU1674673428.USD","BK4532","LU0823416689.USD","IBB","LU1066053197.SGD","LU1934455194.USD","LU2357627491.SGD","BBH","BK4568","SG9999015986.USD","LU0861579265.USD","LU1066051498.USD","BK4588","LU0234570918.USD","LU0889565916.HKD","LU1037948897.HKD","BIB","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0859254822.USD","IE00B19Z3581.USD","BK4566","SG9999015952.SGD","TMED","LU0109394709.USD","LU1839511570.USD","IBBQ","GILD","LU0058720904.USD","LU1023059063.AUD","LU1061106388.HKD","MEDI","IE00B19Z3B42.SGD","LU1585245621.USD","BK4585","BMED","LU1674673691.USD","BK4583","LU2087621335.USD","SG9999015945.SGD","LU2324357040.USD","LU0965509283.SGD","TBXU","LU1571399168.USD","LU0122379950.USD","LU1934455863.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603529","title":"Health Care Down on Rotation to Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603529","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662603529?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:26","pubTimestamp":1787865960,"startTime":"0","endTime":"0","summary":"Health-care companies fell as traders rotated out of defensive sectors back into the high-risk tech sector.Novo Nordisk shares slipped after analysts at brokerage Deutsche Bank cut their rating on the Ozempic maker, warning that a recent deceleration in sales growth could continue. Intensified competition from Eli Lilly and smaller rivals has weighed on the Danish giant's earnings in recent quarters, as it gives up some of its early lead on the wildly popular GLP-1 category of drugs.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","XBI","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662112039","title":"Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™","url":"https://stock-news.laohu8.com/highlight/detail?id=2662112039","media":"GlobeNewswire","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662112039?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:05","pubTimestamp":1787861100,"startTime":"0","endTime":"0","summary":"Kevin Lundquist   Kevin Lundquist  Seasoned finance executive brings more than 20 years of leadership experience across global commercial organizations, including the pharmaceutical and medical techno","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352397/0/en/outlook-therapeutics-appoints-kevin-lundquist-as-chief-financial-officer-as-it-prepares-for-u-s-commercial-launch-of-lytenava.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNAV","WUGI","ILDR","AMDG","BK4512","PSI","ARTY","LU0133085943.USD","SMH","LABU","DAMD","AMDY","IETC","USXF","LU2896262040.SGD","AMYY","AIS","BAI","CHPS","AMUU","AMDL","BK4007","SGXZ51526630.SGD","SMHX","LENZ","SOXX","FAI","AMDD","QQQA","SAMD0main","IEIH","AIQ","LU1852331112.SGD","SGXZ81514606.USD","SOXY","WISE","LEGR","XNTK","TTEQ","AMDW","CHAT","AMDC","GAMR","TRFK","TEK","AMDU","AMD","LU0127658192.USD","AMDS","FTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662003883","title":"Roivant Sciences Gets FDA Approval for LISRAYA in Dermatomyositis; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2662003883","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662003883?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860715,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) said Thursday the FDA approved LISRAYA for adults with dermatomyositis, with the once-daily pill now available in the US, sending its shares up 1.5%.The approval follows the Ph","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4585","BK4007","ROIV","PTH","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":4,"totalSize":396,"code":"91000000","status":"200"}]}}